Organic Syntheses, CV 9, 516
Submitted by Spencer Knapp and Frank S. Gibson
1.
Checked by Chris Melville and James D. White.
1. Procedure
CAUTION! The following operations produce lachrymatory and corrosive vapors and must be carried out in a well-ventilated fume hood.
A.
2-Cyclopentene-1-acetamide. A
dry, 250-mL, three-necked, round-bottomed flask is equipped with a magnetic stirring bar, serum stopper, 25-mL pressure equalizing addition funnel, and an
argon atmosphere with provision for venting gaseous reaction products (Note
1). The vessel is charged with
20 g (152 mmol) of 2-cyclopentene-1-acetic acid (Note
2) and
25 mL of dry toluene (Note
3).
Oxalyl chloride (17.3 mL, 1.3 equiv) is added slowly over a 30-min period by means of the addition funnel, taking care to release any pressure buildup. (
Caution: gaseous hydrogen chloride evolution!.) The dark reaction mixture is stirred for an additional 20 min while the second reaction vessel is assembled, then concentrated to about 2/3 volume at the vacuum pump (Note
4).
A
250-mL, three-necked, round-bottomed flask equipped with magnetic stirring bar, serum stopper, dry ice condenser, and
argon atmosphere is cooled by means of a
dry ice/acetone bath and charged with approximately
150 mL of dry liquid ammonia. The
2-(2-cyclopentenyl)acetyl chloride reaction mixture is added carefully but steadily (Note
5) to the cold and rapidly stirred
ammonia by syringe. (
Caution: vigorous exothermic reaction!). Residual acid chloride is transferred by rinsing the first vessel with
5 mL of toluene. After the addition the mixture is stirred for an additional 5 min, then
60 mL of dichloromethane is added. The cold bath is removed and the excess
ammonia is allowed to escape into the fume hood by stirring the open vessel overnight.
The crude reaction mixture is filtered and the filtrate is reserved. The solids are triturated by stirring vigorously with
100 mL of methanol for 20 min with gentle warming to about 40°C. The solids are filtered and triturated again in the same way. The three organic filtrates are combined and concentrated to near dryness. The resulting semi-solid is redissolved in
100 mL of dichloromethane, filtered to remove residual
ammonium chloride, and concentrated to a light brown solid, 18.9 g. The crude product is dissolved in
60 mL of boiling tetrahydrofuran and allowed to crystallize in a −6°C freezer overnight. The amide is collected by filtration, washed with
5 mL of cold ether, and dried under reduced pressure, giving
15.77 g of white flakes, mp
128–129°C. The filtrate is concentrated to about 8 mL, brought to the cloud point by the addition of a few drops of
hexane, and cooled in the freezer. Filtration as before gives a second crop of white flakes,
1.46 g, mp
128–129°C (total yield
17.23 g,
90.6%) (Note
6).
B.
8-exo-Iodo-2-azabicyclo[3.3.0]octan-3-one. A
dry, 500-mL, three-necked, round-bottomed flask equipped with magnetic stirring bar, serum stopper, 50-mL pressure-equalizing addition funnel, cold water bath, and
argon atmosphere is charged with
12.5 g (100 mmol) of 2-cyclopentene-1-acetamide,
29.2 mL (210 mmol) of triethylamine (Note
7), and
80 mL of dry pentane (Note
8). By means of the addition funnel,
41 mL (210 mmol) of trimethylsilyl trifluoromethanesulfonate (Note
9) is slowly added to the cooled and rapidly stirred amide suspension over a 50-min period. After the addition is complete, the reaction mixture is stirred for an additional 20 min at room temperature, then the stirring is stopped, and the two layers are allowed to separate.
A second,
dry, 500-mL, three-necked, round-bottomed flask is equipped with magnetic stirring bar, serum stopper, vacuum pump connection, and
argon atmosphere. The (top) pentane layer from the first flask, which contains the bis(trimethylsilyl)imidate, is carefully transferred to the second flask by
cannula, maintaining the
argon atmosphere, and leaving the oily triethylammonium trifluoromethanesulfonate layer behind. This remaining salt is triturated with
30 mL of a dry 2:1 pentane/ether mixture by stirring for 15 min, allowing the layers to separate, then transferring the extract to the second flask as before. The trituration is repeated with a
30-mL portion of anhydrous ether, and the combined extracts in the second flask are concentrated with stirring to about 1/3 volume using the vacuum pump (Note
10).
A third, dry,
500-mL, three-necked, round-bottomed flask equipped with an addition funnel, magnetic stirring bar, serum stopper, cold water bath, and
argon atmosphere is charged with
53.3 g (210 mmol) of molecular iodine and
140 mL of anhydrous ether. The mixture is allowed to stir for 10 min to dissolve most of the
iodine. The concentrated organic extract in the second flask is now added to the
iodine solution with stirring and cooling over 15 min. The reaction mixture warms slightly during the addition, but should not reach reflux. An additional
10 mL of anhydrous ether is used to complete the transfer of the bis(trimethylsilyl)imidate. Near the end of the addition, the oily black layer (which contains the cyclized iminium salt) solidifies, leaving a clear light brown ether supernatant. The serum stopper is carefully removed and the solid residue gently broken up using a spatula. The stopper is replaced and the reaction mixture is allowed to stand for an additional 45 min with occasional swirling by hand. The reaction is quenched by removing the addition funnel and stopper and slowly adding
20 mL of saturated aqueous sodium carbonate. (
Caution: vigorous gas evolution!). At this point stirring can be resumed. A
20-mL portion of saturated aqueous sodium sulfite is added slowly (
more gas evolution), and the process is repeated until
100 mL each of saturated aqueous sodium carbonate and sulfite have been added. The reaction mixture is filtered, the crude solid iodolactam is reserved, and the organic layer is separated and reserved. The aqueous layer is saturated with
sodium chloride and extracted with four,
100-mL portions of dichloromethane. The five organic extracts are combined, dried over
anhydrous sodium sulfate, and concentrated to a light brown solid. This residue is dissolved in
20 mL of tetrahydrofuran and hexane is added to the cloud point. Cooling in the freezer gives colorless needles, which are collected and dried under reduced pressure to afford
1.60 g of iodolactam, mp
138–139°C.
The reserved solid from filtration is dried under reduced pressure, dissolved in
65 mL of hot tetrahydrofuran and filtered. The solution is allowed to cool, first at room temperature, then in the freezer. The product (
16.77 g, mp
138–139°C) is collected as before. The mother liquor is concentrated to about 10 mL, brought to the cloud point by the addition of
hexane, and cooled in the freezer, resulting in an additional crop of
1.70 g, mp
138–139°C. The total amount of iodolactam is
19.80 g, representing a
79% yield from the amide (Note
11).
2. Notes
1. All reaction glassware was oven dried at 120°C and assembled hot. The submitters used three evacuate/fill cycles from an
argon-filled balloon fitted on a three-way stopcock to provide the inert atmosphere.
3.
Toluene was dried by distillation from −40 mesh
calcium hydride. Unless otherwise specified, reagents in this procedure were obtained commercially and used as received.
4. In series with the usual
(500 mL) dry ice/acetone trap, a trap filled with solid
sodium hydroxide was used to protect the pump from acidic vapors.
5. Continuous addition of the carboxylic acid chloride solution is required to prevent clogging the syringe needle.
6. The spectral properties are as follows: FT-IR (KBr) cm
−1: 3360, 3355, 1663, 1634;
1H NMR (400 MHz, CDCl
3) δ: 1.42–1.49 (m, 1 H), 2.07–2.35 (m, 5 H), 3.06–3.09 (m, 1 H), 5.66 (br s, 1 H), 5.75 (app dd, 1 H, J = 2, 5), 5.76 (app dd, 1 H, J = 2.5, 4.5), 5.94 (br s, 1 H);
13C NMR δ: 29.6, 31.8, 42.0, 42.3, 131.7, 133.7, 175.0.
10. Any adventitious water introduced during these operations results in a decreased yield of iodo lactam and the formation of iodo lactone as an undesired side product.
11. The spectral properties are as follows: FT-IR (KBr) cm
−1: 3189, 3078, 3034, 1680;
1H NMR (400 MHz, CDCl
3) δ: 1.55–1.60 (m, 1 H), 1.99–2.06 (m, 1 H), 2.10–2.20 (m, 2 H), 2.33–2.45 (m, 1 H), 2.70 (dd, 1 H, J = 18, 10), 3.05–3.13 (m, 1 H), 4.16 (br s, 1 H), 4.40 (d, 1 H, J = 7.2), 5.75–5.85 (br s, 1 H);
13C NMR δ: 32.3, 32.9, 35.0, 35.5, 38.2, 69.8, 178.6.
Waste Disposal Information
All toxic materials were disposed of in accordance with "Prudent Practices in the Laboratory"; National Academy Press; Washington, DC, 1995.
3. Discussion
This "iodolactamization" procedure has been optimized for the present example. Related reaction conditions have been used to generate a series of iodo lactams from the corresponding unsaturated amides (Table).
2,3 For these (smaller scale) examples, the cyclization was carried out in
tetrahydrofuran solution, and isolation was by column chromatography. The lactams in entries 3, 4, and 8 have also been prepared by the submitters in
81%,
82%, and
78% yields, respectively, using the procedure described herein. Cyclization in
ether solution rather than in
tetrahydrofuran avoids the formation of
iodobutanol,
3 which must then be separated from product.
Iodo lactams are a useful, new class of difunctional compounds.
2 Conversions of iodo lactams to N-acylaziridines,
3,4 unsaturated lactams,
3,5 azido lactams,
3,4 amino lactams,
3,4 hydroxy lactams,
3 seleneno lactams,
6 7 annulated lactams,
3,6,7,8 and other derivatives
2 have been described. Syntheses of
ezoaminuroic acid5 and slaframine
6,7 have used halo lactamizations for key steps. Halo lactams have also been prepared from
aspartic acid8 and
glutamic acid,
9 from N-substituted unsaturated amides
10,11 12 13,14 and imidates,
15,16,17 and from unsaturated amides whose competing O-cyclization reaction is less favored.
18,19 20
TABLE
PREPARATION OF IODO LACTAMS
|
Entry |
Unsaturated Amide |
Iodo Lactam(s) |
% Yield (cis/trans) |
|
1 |
|
|
35a |
2 |
|
|
35b |
3 |
|
|
86 |
4 |
|
|
88 |
5 |
|
|
84 (3:1) |
6 |
|
|
88 (2:1) |
7 |
|
|
86 (1:1) |
8 |
|
|
80c |
|
a10–20% of starting amide was also recovered. b54% of crotonamide was also isolated. cOverall yield after separate desilylation.
|
Copyright © 1921-2002, Organic Syntheses, Inc. All Rights Reserved